• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Departures HCV


<























































Bye bye 2nd generation!! Only so much $s for R&D and it is now going into oncology. See ya Louie and Lootzie! Do not follow me to my new company and in our district this week there are 3 reps that have gone on to greener pastures. Sayonara!
 








How could any of you believe that this was a worthwhile gamble???? No sympathy for any of you, sorry to be a douche but this was doomed to fail before it started - 240 reps, account executives (worthless, totally worthless wastes of money) and a product that is one step easier to take than boceprevir. I kicked the tires last year and the retread of a hiring manager was all I needed to come to the conclusion to pass on it.
 
















Similar threads

Replies
17
Views
3K
AbbVie
Anonymous
Replies
1
Views
2K
AbbVie
anonymous
Replies
0
Views
1K
AbbVie
anonymous
Replies
2
Views
1K
AbbVie
anonymous
Replies
4
Views
2K
AbbVie
anonymous